We are proud of our PI Lars Maegdefessel, professor of vascular biology at TUM, who just won a prestigious ERC Consolidator Grant for his project “Targeting long non-coding RNAs for novel treatment strategies in vascular diseases” (LongTx). In 2015, he already received an ERC Starting Grant.
The grants are awarded annually in several categories. Consolidator Grants are provided to researchers with between seven and 12 years’ experience since completion of a doctorate. The selected projects will receive up to 2 million euros in funding.
In his project LongTx, Prof. Lars Maegdefessel will investigate how lncRNAs can be used to develop better treatments for vascular diseases. He is particularly interested in atherosclerosis in vessels supplying the brain – one of the main causes of strokes. Using a combination of different methods, Maegdefessel and his team have already identified several lncRNAs that play a role in the development of vascular diseases. Now they want to investigate their function and therapeutic potential in preclinical test series in order to develop them further for future treatment strategies.